Of the nonspecific sources of financial support the major one is, of course, the Medical Research Council. This does not appear to set aside any specific sum for rheumatism research and any applications within this field are referred to either the Clinical or Biological Research Boards depending upon the type of investigation involved. Interviews of applicants by the assessing committees are not undertaken. In addition to its grants for individual projects the Council maintains its own rheumatism unit at Taplow and an increasing amount of research in rheumatism and related subjects is being undertaken at the Clinical Research Centre. No published figures are available from which to assess the Council's total financial commitment in the field of rheumatism.
In addition to the MRC, government financed medical research takes place via the Regional Hospital Boards, each of which distributes about £25 000 per annum making a total of about £300 000. This, however, covers all varieties of medical research in Regional Board Hospitals and it is doubtful whether rheumatism research ever claims more than about 10% of this in any one year. The methods of assessment of application probably vary between the regions. In the North West Metropolitan Region this is delegated to a Clinical Research Subcommittee with appropriately co-opted members.
Although there are innumerable other grantgiving bodies, both large and small, there is apparently none apart from those already mentioned which encourages rheumatism research, and there are several which may even appear to discourage it. Dr The support given to research on diseases of farm livestock should be expected to bear some relationship to needs and priorities, it being accepted that the results of successful research on animal disease are bound to be of benefit. The decisions about the content of a research programme in this field can be restricted to choosing the disease problems of greatest priority with solutions of greatest potential value and for which the available expertise and facilities are appropriate. 'Value' in this context can be considered in very broad terms. Animal production in the developed countries is tending to be more and more artificial under conditions of increasing intensification. Research is expected to prevent or correct disorders arising from pushing productivity to the limit in systems in which animal welfare is not obviously the most important component. Research, to be of value, must usually be related to attempts to reduce the economic losses caused by disease. There are exceptions, however, from the opposite extreme of profit motivation. Research on the prevention of canine rabies, the prevalence of which is usually low in the dog population even in endemic areas, is something that merits support because of the distressing features of the infection in man. Nor should it be overlooked that from the ethical, moral and animal welfare point of view every effort should be made to eliminate or control disease once the means for doing so are available.
Animal disease research in general, however, has always been subject to strong cost-benefit considerations. This is to be expected when policies of prophylaxis or therapy are decided on their economic advantages in comparison with those of slaughter. This applies to the case of the individual animal as well as to flocks and herds. This materialistic approach must be borne in mind by the veterinary surgeon in large animal practice.
In the United Kingdom, the principal support for animal disease research is provided by the Agricultural Research Council, the Ministry of Agriculture, Fisheries and Food, the Overseas Development Administration, commercial producers of biological products, specialized agencies such as the Meat and Livestock Commission, the Horserace Betting Levy Board and by organizations such as the Wellcome Trust.
The largest block of funds for agricultural research is administered by the Agricultural Research Council. Reference to the Council's Annual Report for 1970/71 shows that current expenditure at institutes and units amounted to £16.5 million. Of the broad division between animals and plants, £7.2 million was for the former category and of this about one-third, namely, £2.3 million, was in support of animal disease research. Support from other government funds is less than this. For example, the total for all research and development in the Ministry of Agriculture, Fisheries and Food was £6.2 million for 1971/72 (Cmnd 4814, 'A framework for government research and development'). Examples S Section ofComparative Medicine of other support for animal disease research are: the Wellcome Trust £200 000; the Meat and Livestock Commission £50 000; the Horserace Betting Levy Board approximately £100 000, almost exclusively on equine matters. It is obvious, therefore, that the total annual expenditure on animal disease research in the United Kingdom, excluding private industry's contribution, does not exceed £5 million. This should be measured against the output value of the animal industry and the losses attributable to disease. A recent estimate of the annual output value of cattle, sheep, pigs and poultry was £1526 million which, incidentally, is about two-thirds the total for agriculture. Disease research support is, therefore, a mere 0.3 % of this sum. Estimates of losses due to animal disease are much more difficult to assess. The same disproportion exists, however. At Compton we are spending some £78 000 on the investigation of respiratory infections of calves, the annual loss attributable to this condition being between £5 million and £10 million.
In the absence of reliable data on losses due to animal disease it is most encouraging to see the publication from the Department of Agriculture of the University of Reading by P R Ellis (1972), 'An economic evaluation of the swine fever eradication programme in Great Britain using cost-benefit analysis techniques'. Reference has already been made to the materialistic approach that is required in agriculture and increasing use must be made of the techniques used by Mr Ellis but prior to launching eradication programmes, not some years after.
The future of agricultural research has, of course, been a matter for much debate during recent months which has rather overshadowed the fact that there has already been considerable discussion about the future programmes of agricultural research with the generally accepted conclusion that there is an urgent need to increase the amount of research on animals. The areas which should receive the most emphasis are reproduction, production and reduction of wastage. These are all subjects of some complexity as they apply to our agricultural scene and all are costly in terms of financing research. The current government limitation on research growth will not make the solution of the pertinent problems any easier and the weight of responsibility on those directing research is heavy if we are to make the most of our limited resources. Perhaps one of the most unpalatable messages in Lord Rothschild's report (Cmnd 4814) was that, in his opinion, we were not the best able to make the appropriate judgments. In the process of keeping research under review and of promoting it where necessary there are problems in the selection of priorities. These have to be chosen with the interest of the community as a whole in mind. Research is an investment in the long-term as well as in the short-term future, so that in addition to research with specific endpoints it is necessary to conduct research into the understanding of disease processes and organisms and the development of emerging possibilities. This is the 'strategic' research through which much of the end-point research becomes feasible. Further, there is a need to maintain and develop the various disciplines; the ARC shares with the other research councils a collective responsibility for the development of science. In the carrying out of research there are important questions of co-ordination to avoid both duplication and fragmentation.
As well as carrying out research in institutes, the ARC supports research in universities through grants. These grants are a flexible means of supporting the growing points of research and they are an important source of finance for the research training of postgraduate students, but there are problems arising out of the short-term nature of the support.
As part of its general review activities, the ARC holds conferences of research workers to exchange views and to discuss promising future directions for research.
In its arrangements to support research the Council is guided by a number of Visiting Groups and of Committees representing a wide range both ofexpertise and of the interests of the various users of research.
